Title
Uticaj polimorfizma Fokl gena za vitamin D receptor i TNFa-308 gena za faktor nekroze tumora na težinu i ishod bolesti kod dece sa juvenilnim idiopatskim artritisom
Creator
Lazarević, Dragana S. 1978-
Copyright date
2016
Object Links
Select license
Autorstvo-Nekomercijalno-Bez prerade 3.0 Srbija (CC BY-NC-ND 3.0)
License description
Dozvoljavate samo preuzimanje i distribuciju dela, ako/dok se pravilno naznačava ime autora, bez ikakvih promena dela i bez prava komercijalnog korišćenja dela. Ova licenca je najstroža CC licenca. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/deed.sr_LATN. Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/legalcode.sr-Latn
Language
Serbian
Cobiss-ID
Theses Type
Doktorska disertacija
description
Datum odbrane: 29.11.2017.
Other responsibilities
mentor
Vojinović, Jelena
predsednik komisije
Pašić, Srđan
član komisije
Jevtović-Stoimenov, Tatjana
Academic Expertise
Medicinske nauke
University
Univerzitet u Nišu
Faculty
Medicinski fakultet
Group
Katedra za pedijatriju
Alternative title
Influence of vitamin D receptor Fokl and tumor necrosis factor TNa-308 gene polymorphism on severity and long term outcome in juvenile idiopathic arthritis
Publisher
[D. S. Lazarević]
Format
129 listova
description
Biografija: list 129,
description
pediatrics / reumatology
Abstract (en)
Оur main objective was to investigate possible influence of tumor necrosis factor alpha (TNF-α-308) and FokI Vitamin D receptor (VDR) gene polymorphism on long term disease outcome in JIA patients treated with biologics. We have retrospectively analyzed data from our registry of JIA patients treated with biologics in whom 6 years follow-up data could be obtained and genomic deoxyribonucleic acid (DNA) extracted to test TNF-α–308 promoter and FokI VDR polymorphism. Disease activity was evaluated by ACR Pedi core set criteria for inactive disease. Among 78 JIA patients was not significant distribution difference of TNF-α-308 and FokI VDR gene polymorphism among different JIA subtypes. Patients with -308 GG (p=0,004) and GA (p=0,026) genotype achieved clinical response significantly more frequently than those with the -308 AA genotype after 36 month of follow up period. Patients with FF (p=0,006) and Ff (p=0,036) genotypes had a reduction of disease activity and more frequently reached clinical response to biologics with respect to the ff genotype at the end of the observational period. There was no influence of distribution of the -308 TNF-α on achieving remission, but there was different distribution of FokI polymorphism on possibility to achieve remission at the end of the observational period. Patients resistant to biologics had significantly more frequent ff genotype, while those achieved remission had significantly more frequent Ff genotype (χ2=6,52, p=0,038). JIA patients carrying TNF-α-308 AA genotype and those with VDR ff genotype despite biological treatment, have lesser chance to achieve remission.
Authors Key words
Juvenilni idiopatski artritis, TNF-α-308 polimorfizam gena za TNF, FokI polimorfizam gena za vitamin D receptor, ishod bolesti
Authors Key words
juvenile idiopathic arthritis, TNF-α-308 polymorphism, FokI VDR polymorphism, disease outcome
Classification
616-002.77-053.2-08:575.22(043.3)
Subject
B 660, B 220, B 580
Type
Tekst
Abstract (en)
Оur main objective was to investigate possible influence of tumor necrosis factor alpha (TNF-α-308) and FokI Vitamin D receptor (VDR) gene polymorphism on long term disease outcome in JIA patients treated with biologics. We have retrospectively analyzed data from our registry of JIA patients treated with biologics in whom 6 years follow-up data could be obtained and genomic deoxyribonucleic acid (DNA) extracted to test TNF-α–308 promoter and FokI VDR polymorphism. Disease activity was evaluated by ACR Pedi core set criteria for inactive disease. Among 78 JIA patients was not significant distribution difference of TNF-α-308 and FokI VDR gene polymorphism among different JIA subtypes. Patients with -308 GG (p=0,004) and GA (p=0,026) genotype achieved clinical response significantly more frequently than those with the -308 AA genotype after 36 month of follow up period. Patients with FF (p=0,006) and Ff (p=0,036) genotypes had a reduction of disease activity and more frequently reached clinical response to biologics with respect to the ff genotype at the end of the observational period. There was no influence of distribution of the -308 TNF-α on achieving remission, but there was different distribution of FokI polymorphism on possibility to achieve remission at the end of the observational period. Patients resistant to biologics had significantly more frequent ff genotype, while those achieved remission had significantly more frequent Ff genotype (χ2=6,52, p=0,038). JIA patients carrying TNF-α-308 AA genotype and those with VDR ff genotype despite biological treatment, have lesser chance to achieve remission.
“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.